Compare Non-Statin Options for LDL Lowering

April 2023

We’re getting questions about which non-statin to use for LDL lowering...due to recent headlines about Nexletol (bempedoic acid).

So far, Nexletol is only approved for certain patients who need more LDL lowering...despite max tolerated statins.

Now new data suggest that Nexletol prevents 1 CV event for every 63 patients at high CV risk treated for about 3 years.

 

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote